fashion -WSS

fashion

author：focus 2025-10-03 20:29:39 - browse：8399

Walmart seems poised to increase its health care footprint by buying value-based senior care company ChenMed. Joe Raedle/Getty Images

Walmart seems poised to increase its health care footprint by buying value-based senior care company ChenMed, per reports from Bloomberg.

Experts largely hailed the rumored sale as a good buy, citing the management of chronic conditions in the Medicare Advantage population through primary care, ChenMed’s specialty, as an area with huge innovation and cost savings over the last 10 years.

“If you’re going to purchase primary care in the senior space, there’s no one better than ChenMed. The only other one that might be better or equivalent would be Oak Street, but they were just purchased,” said Jon Kaplan, a senior partner at BCG. “In the world of great primary care practices to buy, in my top two are Oak Street and ChenMed, and one of them’s available, one’s not.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Air quality improving but still lags in Black, Hispanic communities

entertainment

WSS

NEJM study link tiny plastics in blood vessels to heart problems

Readers respond to H5N1 and livestock movements, and more

With measles on the rise, a personal story of a devastating disease

Headspace, Meta partner to launch VR meditation app for Quest

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Wikipedia

fashion

focus

Bright Health sells Medicare Advantage business to Molina

Air quality improving but still lags in Black, Hispanic communities

Activists slam private health insurers over coverage restrictions

A deep dive into Applied Therapeutics’ data, and questions on Cassava

The cancer drug shortage isn’t new — and neither are the solutions

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Trump demands the U.S. pay no more for drugs than other countries … again

CDC marks new Covid

Virginia high school admissions case could be legal follow

Novo Nordisk obesity pill bests Wegovy in early trial

hotspot

Novo Nordisk obesity pill bests Wegovy in early trial

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

The problem with charging patients to message their doctors

Readers respond to H5N1 and livestock movements, and more

Arc Institute generative AI designs new CRISPR systems

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

knowledge

entertainment

hotspot

hotspot